Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul><li>Friday Takeaway—delving a little deeper into UK small caps Friday Takeaway from UK Small Caps This will delve a little deeper on individual companies and focus on non-house stocks under £200m market capitalisation to raise awareness 14th March 2025 Alphabetically arranged Share prices and market capitalisations taken from Alpha Terminal from the current price on the day of publication.</li><li>Top three shareholders are taken from the websites of the companies that we are writing about, unless there is a more up to date TR-1 notification RNS announcement.</li><li> Disruptive changes could generate opportunities for these two companies ABDX Flowing Downhill NXQ Follow the Money Abingdon Health 6.75p £12.32m (ABDX) Financial Calendar: Year End June, Report October, Interims December, Report April Three Main Shareholders: Octopus Investments Limited 10.1%, Cannacord Genuity Group Inc 9.7% Mercia 9.3% Key Investment Points: Fund Raise, Acquisition, US office Opened, Growth should follow Interims to December 2024 are due to be reported by this lateral flow test contract research (CRO) and contract development and manufacturing organisation (CDMO).</li></ul>

Friday Takeaway—delving a little deeper into UK small caps Friday Takeaway from UK Small Caps This will delve a little deeper on individual companies and focus on non-house stocks under £200m market capitalisation to raise awareness 14th March 2025 Alphabetically arranged Share prices and market capitalisations taken from Alpha Terminal from the current price on the day of publication.Top three shareholders are taken from the websites of the companies that we are writing about, unless there is a more up to date TR-1 notification RNS announcement. Disruptive changes could generate opportunities for these two companies ABDX Flowing Downhill NXQ Follow the Money Abingdon Health 6.75p £12.32m (ABDX) Financial Calendar: Year End June, Report October, Interims December, Report April Three Main Shareholders: Octopus Investments Limited 10.1%, Cannacord Genuity Group Inc 9.7% Mercia 9.3% Key Investment Points: Fund Raise, Acquisition, US office Opened, Growth should follow Interims to December 2024 are due to be reported by this lateral flow test contract research (CRO) and contract development and manufacturing organisation (CDMO).

Nexteq PLC - Friday Take Away: 14 March 2025

<ul>
<li>1Spatial 60.5p £67.4m (SPA.L) The global leader in Location Master Data Management software, and solutions updates on trading for FY January 2025.</li>
<li>Progress is made against its strategic objectives of solving complex geospatial data challenges to drives higher margin recurring software revenue.</li>
<li>Its revenues increased 3.4% to £33.4m and it exceeded expectations from software sales (term licence and SaaS), with this higher gross margin revenue increasing by over 35% to £11.5m. </li>
</ul>


1Spatial 60.5p £67.4m (SPA.L) The global leader in Location Master Data Management software, and solutions updates on trading for FY January 2025.
Progress is made against its strategic objectives of solving complex geospatial data challenges to drives higher margin recurring software revenue.
Its revenues increased 3.4% to £33.4m and it exceeded expectations from software sales (term licence and SaaS), with this higher gross margin revenue increasing by over 35% to £11.5m. 


External reports (aggregated public sources), Value Investors Club

Value Investors Club

External reports (aggregated public sources)

<ul><li>Manufacturers utilize NXQ's graphical interfaces and touchscreens to enhance user experience and operational efficiency in machinery.</li><li>Nexteq PLC has introduced a new range of gaming cabinets with advanced features and enhanced performance.</li><li>The company remains committed to delivering innovative solutions in multiple industries, prioritizing improved user experiences and operational efficiency through their technology.</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

Manufacturers utilize NXQ's graphical interfaces and touchscreens to enhance user experience and operational efficiency in machinery.Nexteq PLC has introduced a new range of gaming cabinets with advanced features and enhanced performance.The company remains committed to delivering innovative solutions in multiple industries, prioritizing improved user experiences and operational efficiency through their technology.This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Nexteq Plc (NXQ.L) - Tuesday, Feb 6, 2024

United Kingdom

Nexteq PLC designs and manufactures gaming hardware and software solutions for the pay-for-play gaming and slot machine industry. The Company provides specialized gaming platforms designed specifically for gaming and slot machine applications.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00